Journal
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
Volume 50, Issue -, Pages 131-156Publisher
ANNUAL REVIEWS
DOI: 10.1146/annurev.pharmtox.010909.105844
Keywords
rRNA genes; transcription; nucleolus; signaling; drugs; apoptosis
Categories
Funding
- Deutsche Forschungsgemeinschaft
- European Community
- Fonds der Chemischen Industrie
- Cylene Pharmaceuticals
Ask authors/readers for more resources
The RNA polymerase I (Pol I) transcription machinery in the nucleolus is the key convergence point that collects and integrates 1 vast array of information cellular signaling cascades to regulate ribosome production that in turn guides cell growth and proliferation. Cancer cells commonly harbor mutations that inactivate tumor suppressors, hyperactivate oncogenes, and upregulate protein kinases, all of which promote Pol I. transcription and drive cell proliferation. The intimate balance between Pol I transcription and growth-factor signaling is perturbed in cancer cells, indicating that upregulation of rRNA synthesis is mandatory for all tumors. Though the emerging Picture of transcriptional regulation reveals an unexpected level of complexity, we are beginning to understand the multiple links between rRNA biogenesis and cancer. In this review, we discuss experimental data and potential strategies to downregulate rRNA synthesis and induce an antiproliferative response in cancer cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available